Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 49 articles:
HTML format
Text format



Single Articles


    April 2018

  1. More on Adjuvant Therapy in Resected Melanoma.
    N Engl J Med. 2018;378:1656-1657.
    PubMed     Text format    


  2. EGGERMONT AMM, Blank CU, Mandala M, Long GV, et al
    Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.
    N Engl J Med. 2018 Apr 15. doi: 10.1056/NEJMoa1802357.
    PubMed     Text format     Abstract available


    February 2018
  3. WEBER J, Qureshi A, Ascierto PA
    Adjuvant Therapy in Resected Melanoma.
    N Engl J Med. 2018;378:680.
    PubMed     Text format    


  4. MARIA ARJ, Viegas Dias C, Heleno B
    Adjuvant Therapy in Resected Melanoma.
    N Engl J Med. 2018;378:679.
    PubMed     Text format    


  5. THOMSON N, Doerr R, Martin MG
    Adjuvant Therapy in Resected Melanoma.
    N Engl J Med. 2018;378:678-9.
    PubMed     Text format    


  6. SLADDEN M, Zagarella S, Bigby M
    Adjuvant Therapy in Resected Melanoma.
    N Engl J Med. 2018;378:678.
    PubMed     Text format    



  7. Adjuvant Therapy in Resected Melanoma.
    N Engl J Med. 2018;378:678-680.
    PubMed     Text format    


    January 2018
  8. CAULLEY L, Balch CM, Ross MI, Robert C, et al
    Management of Sentinel-Node Metastasis in Melanoma.
    N Engl J Med. 2018;378:85-88.
    PubMed     Text format    


    December 2017
  9. ALEGRE-DEL-REY EJ, de la Nogal Fernandez B, Briceno-Casado P
    Nivolumab and Ipilimumab in Advanced Melanoma.
    N Engl J Med. 2017;377:2503.
    PubMed     Text format    


  10. RYU H, Lee HJ
    Nivolumab and Ipilimumab in Advanced Melanoma.
    N Engl J Med. 2017;377:2503.
    PubMed     Text format    


  11. KOURKOUMPETIS T, Jarbrink-Sehgal ME
    Melanoma Metastatic to the Duodenum.
    N Engl J Med. 2017;377:e34.
    PubMed     Text format    


  12. WOLCHOK JD, Rollin L, Larkin J
    Nivolumab and Ipilimumab in Advanced Melanoma.
    N Engl J Med. 2017;377:2503-2504.
    PubMed     Text format    


    November 2017
  13. SCHUCHTER LM
    Adjuvant Melanoma Therapy - Head-Spinning Progress.
    N Engl J Med. 2017;377:1888-1890.
    PubMed     Text format    


    September 2017
  14. WOLCHOK JD, Chiarion-Sileni V, Gonzalez R, Rutkowski P, et al
    Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
    N Engl J Med. 2017 Sep 11. doi: 10.1056/NEJMoa1709684.
    PubMed     Text format     Abstract available


  15. WEBER J, Mandala M, Del Vecchio M, Gogas HJ, et al
    Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.
    N Engl J Med. 2017 Sep 10. doi: 10.1056/NEJMoa1709030.
    PubMed     Text format     Abstract available


  16. LONG GV, Hauschild A, Santinami M, Atkinson V, et al
    Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma.
    N Engl J Med. 2017 Sep 10. doi: 10.1056/NEJMoa1708539.
    PubMed     Text format     Abstract available


    August 2017
  17. BILIMORIA KY, Russell MC, Hyngstrom J
    Melanoma Sentinel-Node Metastasis.
    N Engl J Med. 2017;377:891.
    PubMed     Text format    


  18. FARIES MB, Cochran AJ, Thompson JF
    Melanoma Sentinel-Node Metastasis.
    N Engl J Med. 2017;377:892.
    PubMed     Text format    



  19. Melanoma Sentinel-Node Metastasis.
    N Engl J Med. 2017;377:891-2.
    PubMed     Text format    


    July 2017
  20. COSTELLO CM, Pittelkow MR, Mangold AR
    Acral Melanoma and Mechanical Stress on the Plantar Surface of the Foot.
    N Engl J Med. 2017;377:395-396.
    PubMed     Text format    


    June 2017
  21. COIT D
    The Enigma of Regional Lymph Nodes in Melanoma.
    N Engl J Med. 2017;376:2280-2281.
    PubMed     Text format    


  22. FARIES MB, Thompson JF, Cochran AJ, Andtbacka RH, et al
    Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.
    N Engl J Med. 2017;376:2211-2222.
    PubMed     Text format     Abstract available


    May 2017
  23. GONG HZ, Li J
    Melanoma of the Foot.
    N Engl J Med. 2017;376:1867.
    PubMed     Text format    


    February 2017
  24. KRISTENSEN VN
    The Antigenicity of the Tumor Cell - Context Matters.
    N Engl J Med. 2017;376:491-493.
    PubMed     Text format    


    January 2017
  25. COPUR MS, Ramaekers R, Crockett D
    Ipilimumab Adjuvant Therapy in Melanoma.
    N Engl J Med. 2017;376:398-9.
    PubMed     Text format    


  26. IANIRO G, Gasbarrini A, Cammarota G
    Ipilimumab Adjuvant Therapy in Melanoma.
    N Engl J Med. 2017;376:398.
    PubMed     Text format    


  27. EGGERMONT AMM, Suciu S, Testori A, et al., et al
    Ipilimumab Adjuvant Therapy in Melanoma.
    N Engl J Med. 2017;376:399.
    PubMed     Text format    


    November 2016
  28. JOHNSON DB, Balko JM, Compton ML, Chalkias S, et al
    Fulminant Myocarditis with Combination Immune Checkpoint Blockade.
    N Engl J Med. 2016;375:1749-1755.
    PubMed     Text format     Abstract available


    October 2016
  29. EGGERMONT AM, Chiarion-Sileni V, Grob JJ, Dummer R, et al
    Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


    August 2016
  30. WELLBROCK C
    Melanoma and the Microenvironment--Age Matters.
    N Engl J Med. 2016;375:696-8.
    PubMed     Text format    


    July 2016
  31. DE MALEISSYE MF, Nicolas G, Saiag P
    Pembrolizumab-Induced Demyelinating Polyradiculoneuropathy.
    N Engl J Med. 2016;375:296-7.
    PubMed     Text format    


  32. ZARETSKY JM, Garcia-Diaz A, Shin DS, Escuin-Ordinas H, et al
    Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  33. MARCHALIK RJ, Venna S
    IMAGES IN CLINICAL MEDICINE. Eyelid Melanoma.
    N Engl J Med. 2016;375:75.
    PubMed     Text format    


    June 2016
  34. MINAGAWA A, Omodaka T, Okuyama R
    Melanomas and Mechanical Stress Points on the Plantar Surface of the Foot.
    N Engl J Med. 2016;374:2404-6.
    PubMed     Text format    


    April 2016
  35. VERA-KELLET C, Del Barrio-Diaz P
    IMAGES IN CLINICAL MEDICINE. Oral Amalgam Tattoo Mimicking Melanoma.
    N Engl J Med. 2016;374:e21.
    PubMed     Text format    


    March 2016
  36. JANSEN T, Hoff NP
    IMAGES IN CLINICAL MEDICINE. Diffuse Melanosis Cutis.
    N Engl J Med. 2016;374:1177.
    PubMed     Text format    


  37. LIPSKER D
    The Genetic Evolution of Melanoma.
    N Engl J Med. 2016;374:993-6.
    PubMed     Text format     Abstract available


  38. LIAN CG, Murphy GF
    The Genetic Evolution of Melanoma.
    N Engl J Med. 2016;374:993-6.
    PubMed     Text format     Abstract available


  39. CRISCITO MC, Polsky D, Stein JA
    The Genetic Evolution of Melanoma.
    N Engl J Med. 2016;374:993-6.
    PubMed     Text format     Abstract available



  40. The Genetic Evolution of Melanoma.
    N Engl J Med. 2016;374:993-6.
    PubMed     Text format     Abstract available


  41. VOGELSTEIN B, Kinzler KW
    The Genetic Evolution of Melanoma.
    N Engl J Med. 2016;374:996.
    PubMed     Text format    


    November 2015
  42. CHAN TA, Wolchok JD, Snyder A
    Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma.
    N Engl J Med. 2015;373:1984.
    PubMed     Text format    


  43. SHAIN AH, Yeh I, Kovalyshyn I, Sriharan A, et al
    The Genetic Evolution of Melanoma from Precursor Lesions.
    N Engl J Med. 2015;373:1926-36.
    PubMed     Text format     Abstract available


  44. WARREN MP, Harvey VM
    IMAGES IN CLINICAL MEDICINE. Acral Lentiginous Melanoma.
    N Engl J Med. 2015;373:1864.
    PubMed     Text format    


    September 2015
  45. VALSECCHI ME
    Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
    N Engl J Med. 2015;373:1270.
    PubMed     Text format    


  46. LARKIN J, Hodi FS, Wolchok JD
    Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
    N Engl J Med. 2015;373:1270-1.
    PubMed     Text format    


    July 2015
  47. SHARFSTEIN JM
    A Spotlight on Sunscreen Regulation.
    N Engl J Med. 2015;373:101-3.
    PubMed     Text format    


    May 2015
  48. LARKIN J, Chiarion-Sileni V, Gonzalez R, Grob JJ, et al
    Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


  49. SONG JY
    Intraoral malignant melanoma.
    N Engl J Med. 2015;372:1944.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: